Syenex

🗓 Founded 2022👥 11 employees💰 Last funded Sep 2022
Syenex is a synbio technology company that provides novel delivery vector to genetic medicine developers. Our goal is to make it easier for developers to design, test, and scale curative cell and gene therapies
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2022
Founded
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Syenex?
Syenex has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Syenex last raise funding?
The most recent investment in Syenex recorded on gritt.io was in September 2022.
When was Syenex founded?
Syenex was founded in 2022.
What industry is Syenex in?
Syenex operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.